“Media reports explain it as being a loophole,” says Alliance for Pharmacy Compounding CEO Scott Brunner. “It’s not a loophole. It’s really intentional coverage.” Brunner has expressed frustration regarding how some coverage with the rise of compounding GLP-1s conflates unlicensed pharmacies peddling copyright medication or exploration peptides with credentialed https://johnn282wpd8.wikiconversation.com/user